PD25-10 EVALUATION OF UROLOGIC PATIENT REPORTED PERI-OPERATIVE FINANCIAL TOXICITY

作者：Daniel Au, Jared Starkey, Jeffery S. Thompson, W. Parker · 发表于：The Journal of Urology · 年份：2022 · DOI：10.1097/ju.0000000000002567.10 · 被引用次数：1 · 研究领域：Economic and Financial Impacts of Cancer

You have accessJournal of UrologyCME1 May 2022PD25-10 EVALUATION OF UROLOGIC PATIENT REPORTED PERI-OPERATIVE FINANCIAL TOXICITY Daniel Au, Jared Starkey, Jeffery Thompson, and William Parker Daniel AuDaniel Au More articles by this author , Jared StarkeyJared Starkey More articles by this author , Jeffery ThompsonJeffery Thompson More articles by this author , and William ParkerWilliam Parker More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002567.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Financial toxicity is an area of increasing focus; however, most research has been directed towards chronic illness, acute hospitalizations, or cancer care. Previous urologic research in financial toxicity has focused on oncologic patients where different demographics and clinical courses from benign urologic patients are expected. This disparity in research focus within financial toxicity limits our understanding of the extent of financial toxicity across the spectrum of urologic practice. METHODS: A cross-sectional study of 182 patients undergoing selected oncologic and benign urologic procedures at a single academic medical center was performed. All patients completing robotic assisted laparoscopic prostatectomy (RALP), transurethral resection of bladder tumor (TURBT), radical cystectomy (RC), holmium laser enucleation of the prosta...